Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / RDY - Dr. Reddy's Laboratories Limited (RDY) Q4 2024 Earnings Call Transcript


RDY - Dr. Reddy's Laboratories Limited (RDY) Q4 2024 Earnings Call Transcript

2024-05-07 14:42:05 ET

Dr. Reddy's Laboratories Limited (RDY)

Q4 2024 Earnings Conference Call

May 07, 2024 10:00 AM ET

Company Participants

Richa Periwal - Head of Investor Relations

GV Prasad - Co-Chairman and Managing Director

Parag Agarwal - Chief Financial Officer

Erez Israeli - Chief Executive Officer

Conference Call Participants

Neha Manpuria - Bank of America Merrill Lynch

Kunal Dhamesha - Macquarie Capital Securities

Saion Mukherjee - Nomura Securities

Tarang Agrawal - Old Bridge Capital

Tushar Manudhane - Motilal Oswal Financial Services

Nitesh Dutt - Burman Capital

Ankush Mahajan - Axis Securities

Surya Patra - PhillipCapital India Private Limited.

Madhav Marda - FIL Research

Bino Pathiparampil - Elara Capital

Presentation

Operator

Ladies and gentlemen, good day, and welcome to the Q4 and Full-Year FY2024 Earnings Conference Call of Dr. Reddy's Laboratories Limited. As a reminder, all participant lines will be in the listen-only mode. There will be an opportunity for you to ask questions after the presentation concludes. [Operator Instructions] Please note that this conference is being recorded.

I now hand the conference over to Ms. Richa Periwal. Thank you, and over to you, Ma'am.

Richa Periwal

Thank you. A very good morning and good evening to all of you and thank you for joining us today for the Dr. Reddy's earnings conference call for the quarter and full-year ended, March 31, 2024. Earlier during the day, we have released our results and the same was also posted on our website. This call is being recorded and the playback and transcript shall be made available on our website soon.

All the discussions and analysis of this call will be based on the IFRS consolidated financial statements. The discussion today contains certain non-GAAP financial measures. For a reconciliation of GAAP to non-GAAP measures, please refer to our press release.

To discuss the business performance and outlook, we have the leadership of Dr. Reddy's comprising Mr. GV Prasad, our Co-Chairman and Managing Director; Mr. Erez Israeli, our CEO; Mr. Parag Agarwal, our CFO and the entire Investor Relations team.

Please note that today's call is a copyrighted material of Dr. Reddy's, and cannot be re-broadcasted or attributed in press or media outlets without the Company's expressed written consent. Before I proceed with the call, I would like to remind everyone that the safe harbor contained in today's press release also pertains to this conference call.

Now, I hand over the call to Mr. GV Prasad. Over to you, sir.

GV Prasad

Thank you, Richa. Good morning and good evening to all the participants here. Welcome to the annual earnings call of Dr. Reddy's. I am delighted to be here today along with the members of the management team and the IR team. As many of you know, I joined the earnings call each year at the end of the financial year....

For further details see:

Dr. Reddy's Laboratories Limited (RDY) Q4 2024 Earnings Call Transcript
Stock Information

Company Name: Dr. Reddy's Laboratories Ltd
Stock Symbol: RDY
Market: NYSE
Website: drreddys.com

Menu

RDY RDY Quote RDY Short RDY News RDY Articles RDY Message Board
Get RDY Alerts

News, Short Squeeze, Breakout and More Instantly...